URL | https://www.stocktitan.net/news/SCNI/scinai-immuno |
Source | PRNewswire |
Date Published | 12/16/2024 |
Company/Division name | Scinai Bioservices Inc. |
Parent company | Scinai Immunotherapeutics Ltd |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Year reshoring announced: | 2024 |
Country(ies) from which reshored: | Israel |
State(s) reshored to: | DE |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharma |
What domestic positive factors made reshoring more attractive? | Eco-system synergies |